Science Explorer Back to mapMap
Discussion
Nonprofit · Abingdon · United Kingdom

Against Breast Cancer

againstbreastcancer.org.ukROR OpenAlex
Research works
3
▼ 17% vs 2018-21
Citations
74
29.1 per fractional work
Top-10% rate
0.0%
all institutions 10.0%
Open access
90%
world 40%
International
100%
world 18%
Against Breast Cancer

Not ranked overall: Against Breast Cancer is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Against Breast Cancer work in?

In all years, 60% of research at Against Breast Cancer is in Life Sciences, 40% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (56%), Medicine (40%), Immunology and Microbiology (4%). It does 1.3× the world's share of Life Sciences.

Life Sciences: 2 fractional works · 60.0% of its workBiochemistry, Genetics and Molecular Biology: 1 fractional works · 56.0% of its workImmunology and Microbiology: 0 fractional works · 4.0% of its workHealth Sciences: 1 fractional works · 40.0% of its workMedicine: 1 fractional works · 40.0% of its workALL ITS WORKAgainst BreastCancer2fractional works, all years
Life Sciences60%Health Sciences40%

Each ring splits the one inside it: the four domains of science, their fields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 2 domains and 3 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology156.0%
    2. Immunology and Microbiology04.0%
    1. Medicine140.0%
All of science, and how each field's share has moved since 1950: the Science domain explorer

What are the most cited papers from Against Breast Cancer?

The most cited paper from Against Breast Cancer is "Crucial role of Anxa2 in cancer progression: highlights on its novel regulatory mechanism" (Tong Wang, Zhiyong Wang, Ruifang Niu et al., 2019), with 88 citations. Next come "Clinicopathological characteristics, diagnosis, and prognosis of pregnancy‐associated breast cancer" (71) and "Sentinel node biopsy is reliable in early-stage cervical cancer but not in locally advanced disease" (49).

Most cited papers
#PaperReleasedCitations
1 Crucial role of Anxa2 in cancer progression: highlights on its novel regulatory mechanism Tong Wang, Zhiyong Wang, Ruifang Niu et al. · Cancer Biology and Medicine Open access Nov 2019 88
2 Clinicopathological characteristics, diagnosis, and prognosis of pregnancy‐associated breast cancer Bin Wang, Yanfang Yang, Zhansheng Jiang et al. · Thoracic Cancer Open access 28 Mar 2019 71
3 Sentinel node biopsy is reliable in early-stage cervical cancer but not in locally advanced disease Emmanuel Barranger, Charles Coutant, Annie Cortez et al. · Annals of Oncology Open access 13 May 2005 49
4 Is adjuvant chemotherapy necessary for patients with microinvasive breast cancer after surgery? Haifei Niu, Lijuan Wei, Jinpu Yu et al. · PubMed Open access Mar 2016 12
5 Apoptotic Effects of psiRNA-STAT3 on 4T1 Breast Cancer Cells in Vitro Yue Zhou, Lin Hai Tian, Yingchao Zhang et al. · Asian Pacific Journal of Cancer Prevention Open access 30 Aug 2014 4
All 9 most cited papers, with filters and sorting

Which research topics does Against Breast Cancer publish most on?

By volume in 2022-now: CRISPR and Genetic Engineering, BRCA gene mutations in cancer, PARP inhibition in cancer therapy and Breast Cancer Treatment Studies.

CRISPR and Genetic Engin…0CRISPR and Genetic Engineering: 0 fractional worksBRCA gene mutations in c…0BRCA gene mutations in cancer: 0 fractional worksPARP inhibition in cance…0PARP inhibition in cancer therapy: 0 fractional worksBreast Cancer Treatment …0Breast Cancer Treatment Studies: 0 fractional worksBiomarkers in Disease Me…0Biomarkers in Disease Mechanisms: 0 fractional worksCancer Cells and Metastasis: 0 fractional works
Molecular BiologyGeneticsOncologyCancer Research1 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 CRISPR and Genetic Engineering Molecular Biology 0 works
  2. 2 BRCA gene mutations in cancer Genetics 0 works
  3. 3 PARP inhibition in cancer therapy Oncology 0 works
  4. 4 Breast Cancer Treatment Studies Cancer Research 0 works
  5. 5 Biomarkers in Disease Mechanisms Immunology 0 works
  6. 6 Cancer Cells and Metastasis Oncology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available90.2%not open9.8%

World: 40% of research is openly available.

with international co-authors100.0%

World: 18% is written across borders.

How has Against Breast Cancer's research output changed?

Output in 2022-2025 was 17% lower than in 2018-2021.

still counting2010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Abingdon

All research institutions in Abingdon

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Against Breast Cancer. Posts are plain text and can be reported.